Cargando…
Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
SIMPLE SUMMARY: Most treatment failures in head and neck squamous cell carcinoma (HNSCC) patients are due to the presence of resistant cells. Despite the chemotherapeutic advances that have taken place in recent decades, there are hardly new alternatives for HNSCC patients, with cisplatin being the...
Autores principales: | Garcia-Mayea, Yoelsis, Benítez-Álvarez, Lisandra, Sánchez-García, Almudena, Bataller, Marina, Companioni, Osmel, Mir, Cristina, Benavente, Sergi, Lorente, Juan, Canela, Nuria, Fernández-Rozadilla, Ceres, Carracedo, Angel, LLeonart, Matilde E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688094/ https://www.ncbi.nlm.nih.gov/pubmed/36428603 http://dx.doi.org/10.3390/cancers14225511 |
Ejemplares similares
-
Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021) -
The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021) -
SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021) -
TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2020) -
Autophagy Takes Center Stage as a Possible Cancer Hallmark
por: Alvarez-Meythaler, Jose G., et al.
Publicado: (2020)